Compare · PRKS vs STXS
PRKS vs STXS
Side-by-side comparison of United Parks & Resorts Inc. (PRKS) and Stereotaxis Inc. (STXS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PRKS and STXS operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- PRKS is the larger of the two at $2.14B, about 17.0x STXS ($126.3M).
- Over the past year, PRKS is down 11.6% and STXS is down 49.9% - PRKS leads by 38.4 points.
- STXS has been more active in the news (7 items in the past 4 weeks vs 2 for PRKS).
- PRKS has more recent analyst coverage (8 ratings vs 6 for STXS).
- Company
- United Parks & Resorts Inc.
- Stereotaxis Inc.
- Price
- $44.83+1.55%
- $1.29-8.48%
- Market cap
- $2.14B
- $126.3M
- 1M return
- -4.45%
- -20.80%
- 1Y return
- -11.55%
- -49.90%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NYSE
- AMEX
- IPO
- 2013
- News (4w)
- 2
- 7
- Recent ratings
- 8
- 6
Stereotaxis Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic magnetic navigation (RMN) systems for use in hospital's interventional surgical suite to improve the treatment of arrhythmias and coronary artery disease in the United States and internationally. Its RMN systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. Stereotaxis, Inc. markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is based in St. Louis, Missouri.
Latest PRKS
- UNITED PARKS & RESORTS INC. ANNOUNCES SECOND QUARTER 2026 EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION
- Northcoast initiated coverage on United Parks & Resorts Inc.
- Large owner Hill Path Capital Partners Co-Investment S Lp was granted 1,821 shares (SEC Form 4)
- Large owner Hill Path Capital Partners Lp was granted 1,821 shares (SEC Form 4)
- Director Chambers James P. was granted 1,098 shares, increasing direct ownership by 2% to 65,558 units (SEC Form 4)
- Director Gray William was granted 1,258 shares, increasing direct ownership by 2% to 76,721 units (SEC Form 4)
- Director Hartnett Timothy was granted 1,821 shares, increasing direct ownership by 2% to 81,378 units (SEC Form 4)
- Director Lipman Nathaniel was granted 207 shares, increasing direct ownership by 1% to 20,316 units (SEC Form 4)
- Director Schaefer Kimberly was granted 415 shares, increasing direct ownership by 0.98% to 42,740 units (SEC Form 4)
- Director Narang Neha Jogani was granted 830 shares, increasing direct ownership by 1% to 57,376 units (SEC Form 4)
Latest STXS
- Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026
- University of Szeged Pioneers First Robotic Cardiology Program in Hungary
- Stereotaxis Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form S-3 filed by Stereotaxis Inc.
- SEC Form S-3 filed by Stereotaxis Inc.
- Stereotaxis Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Stereotaxis Completes Acquisition of Robocath
- Director Shamir Nachum was granted 43,103 shares, increasing direct ownership by 32% to 179,327 units (SEC Form 4)
- Director Benfer David was granted 43,103 shares, increasing direct ownership by 8% to 558,975 units (SEC Form 4)
- Director Levin Ross B was granted 43,103 shares, increasing direct ownership by 7% to 621,248 units (SEC Form 4)